company background image
0M0F logo

Tandem Diabetes Care LSE:0M0F Stock Report

Last Price

US$34.67

Market Cap

US$2.3b

7D

10.1%

1Y

-7.5%

Updated

24 Apr, 2024

Data

Company Financials +

Tandem Diabetes Care, Inc.

LSE:0M0F Stock Report

Market Cap: US$2.3b

0M0F Stock Overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

0M0F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Tandem Diabetes Care, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tandem Diabetes Care
Historical stock prices
Current Share PriceUS$34.67
52 Week HighUS$38.27
52 Week LowUS$13.89
Beta1.13
1 Month Change14.69%
3 Month Change52.13%
1 Year Change-7.55%
3 Year Change-60.55%
5 Year Change-45.90%
Change since IPO-8.30%

Recent News & Updates

Recent updates

Shareholder Returns

0M0FGB Medical EquipmentGB Market
7D10.1%2.0%2.7%
1Y-7.5%-8.5%0.3%

Return vs Industry: 0M0F exceeded the UK Medical Equipment industry which returned -8.5% over the past year.

Return vs Market: 0M0F underperformed the UK Market which returned 0.3% over the past year.

Price Volatility

Is 0M0F's price volatile compared to industry and market?
0M0F volatility
0M0F Average Weekly Movement10.7%
Medical Equipment Industry Average Movement8.1%
Market Average Movement4.9%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.7%

Stable Share Price: 0M0F's share price has been volatile over the past 3 months.

Volatility Over Time: 0M0F's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
20062,400John Sheridanwww.tandemdiabetes.com

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body.

Tandem Diabetes Care, Inc. Fundamentals Summary

How do Tandem Diabetes Care's earnings and revenue compare to its market cap?
0M0F fundamental statistics
Market capUS$2.26b
Earnings (TTM)-US$222.61m
Revenue (TTM)US$747.72m

3.0x

P/S Ratio

-10.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0M0F income statement (TTM)
RevenueUS$747.72m
Cost of RevenueUS$380.03m
Gross ProfitUS$367.69m
Other ExpensesUS$590.30m
Earnings-US$222.61m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 02, 2024

Earnings per share (EPS)-3.45
Gross Margin49.18%
Net Profit Margin-29.77%
Debt/Equity Ratio92.4%

How did 0M0F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.